Scholarly Index
Sylvain Ladoire
Inserm; 17,950 total citations; 325 total publications; best world rank #183
Inserm
17,950Total citations
325Total publications
54H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Immunotherapy and Biomarkers | Lifetime | 660 | FR 50 | 98.55 |
| Advanced Breast Cancer Therapies | Lifetime | 571 | FR 31 | 95.54 |
| Advanced Breast Cancer Therapies | 2021-2025 | 183 | FR 15 | 96.86 |
| HER2/EGFR in Cancer Research | 2021-2025 | 235 | FR 15 | 96.32 |
| Breast Cancer Treatment Studies | 2021-2025 | 627 | FR 32 | 93.27 |
| Cancer Treatment and Pharmacology | 2021-2025 | 804 | FR 55 | 86.01 |
| PARP inhibition in cancer therapy | 2021-2025 | 709 | FR 42 | 82.52 |
| Breast Lesions and Carcinomas | 2021-2025 | 686 | FR 10 | 77.87 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 346 | FR 12 | 73.89 |